[{"indications": "Indications\u00a0chronic intractable hypoglycaemia; hypertensive\r\nemergency\u2014but no longer recommended, see section 2.5", "name": "DIAZOXIDE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "6 Endocrine system", "6.1 Drugs used in diabetes", "6.1.4 Treatment of hypoglycaemia", "Chronic hypoglycaemia", "DIAZOXIDE"], "cautions": "Cautions\u00a0ischaemic heart disease; monitor blood pressure; during prolonged use monitor white cell and platelet count, and in children, regularly assess growth, bone, and psychological\r\ndevelopment; interactions: Appendix 1 (diazoxide)", "side-effects": "Side-effects\u00a0anorexia, nausea, vomiting, hyperuricaemia, hypotension,\r\noedema, tachycardia, arrhythmias, extrapyramidal effects; hypertrichosis\r\non prolonged treatment", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/4200.htm", "doses": ["By mouth, adult, initially 5\u00a0mg/kg daily in 2\u20133 divided doses, then adjusted according\r\nto response; usual maintenance dose 3\u20138\u00a0mg/kg daily in 2\u20133 divided\r\ndoses; child 1 month\u201318 years see BNF for Children"], "pregnancy": "Pregnancy\u00a0prolonged use in second or third trimesters may produce\r\nalopecia and impaired glucose tolerance in neonate; inhibits uterine\r\nactivity during labour"}, {"indications": "Indications\u00a0chronic intractable hypoglycaemia; hypertensive\r\nemergency\u2014but no longer recommended, see section 2.5", "name": "DIAZOXIDE - CHRONIC HYPOGLYCAEMIA", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "6 Endocrine system", "6.1 Drugs used in diabetes", "6.1.4 Treatment of hypoglycaemia", "Chronic hypoglycaemia", "DIAZOXIDE"], "cautions": "Cautions\u00a0ischaemic heart disease; monitor blood pressure; during prolonged use monitor white cell and platelet count, and in children, regularly assess growth, bone, and psychological\r\ndevelopment; interactions: Appendix 1 (diazoxide)", "side-effects": "Side-effects\u00a0anorexia, nausea, vomiting, hyperuricaemia, hypotension,\r\noedema, tachycardia, arrhythmias, extrapyramidal effects; hypertrichosis\r\non prolonged treatment", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/4200.htm", "doses": ["By mouth, adult, initially 5\u00a0mg/kg daily in 2\u20133 divided doses, then adjusted according\r\nto response; usual maintenance dose 3\u20138\u00a0mg/kg daily in 2\u20133 divided\r\ndoses; child 1 month\u201318 years see BNF for Children"], "pregnancy": "Pregnancy\u00a0prolonged use in second or third trimesters may produce\r\nalopecia and impaired glucose tolerance in neonate; inhibits uterine\r\nactivity during labour"}, {"indications": "Indications\u00a0hypertensive emergency including severe hypertension\r\nassociated with renal disease (but no longer recommended\u2014see section 2.5); hypoglycaemia\r\n(section 6.1.4)", "name": "DIAZOXIDE - VASODILATOR ANTIHYPERTENSIVE DRUGS", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.5 Hypertension and heart failure", "2.5.1 Vasodilator antihypertensive drugs"], "cautions": "Cautions\u00a0ischaemic heart disease; interactions: Appendix 1 (diazoxide)", "side-effects": "Side-effects\u00a0tachycardia, hypotension, hyperglycaemia, sodium\r\nand water retention; rarely cardiomegaly, hyperosmolar\r\nnon-ketotic coma, leucopenia, thrombocytopenia, and hirsuitism", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2536.htm", "doses": ["By rapid intravenous injection (less than\r\n30\u00a0seconds), 1\u20133\u00a0mg/kg to max. single dose of 150\u00a0mg (see below);\r\nmay be repeated after 5\u201315\u00a0minutes if required", "Single doses of 300\u00a0mg have been associated\r\nwith angina and with myocardial and cerebral infarction"], "pregnancy": "Pregnancy\u00a0prolonged use may produce alopecia, hypertrichosis,\r\nand impaired glucose tolerance in neonate; inhibits uterine activity\r\nduring labour"}]